Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00470015
Status:
COMPLETED
Last Update Posted:
2019-02-19
First Post:
2007-05-03
Brief Title:
Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II Stage III or Stage IV Melanoma
Sponsor:
Organization:
Mayo Clinic